Patents-Review.com
ClassID:

109156 ⎘

C12N2310/311 - CPC Classification

Classification description:

Structure or type of the nucleic acid; Chemical structure of the backbone Phosphotriesters

Recent Application in this class:
#1
20260109728
2026-04-23

IMMUNOMODULATING POLYNUCLEOTIDES, ANTIBODY CONJUGATES THEREOF, AND METHODS OF THEIR USE

 #2
20240124895
2024-04-18

NUCLEASE-MEDIATED GENOME EDITING OF PRIMARY CELLS AND RELATED KITS

 #3
20230399659
2023-12-14

EXOSOMAL LOADING USING HYDROPHOBICALLY MODIFIED OLIGONUCLEOTIDES

 #4
20230235332
2023-07-27

TREATMENT OF NEUROLOGICAL DISEASES USING MODULATORS OF GENE TRANSCRIPTS

 #5
20220195439
2022-06-23

TREATMENT OF GLIAL CELL DERIVED NEUROTROPHIC FACTOR (GDNF) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO GDNF

 #6
20220154182
2022-05-19

ANTISENSE OLIGONUCLEOTIDE-BASED PROGRANULIN AUGMENTATION THERAPY IN NEURODEGENERATIVE DISEASES

 #7
20220064676
2022-03-03

Pharmaceutical compositions comprising gene-corrected primary cells

 #8
20220056069
2022-02-24

IMMUNOMODULATING POLYNUCLEOTIDES, ANTIBODY CONJUGATES THEREOF, AND METHODS OF THEIR USE

 #9
20220025409
2022-01-27

Nuclease-mediated genome editing of primary cells

 #10
20210380982
2021-12-09

Antisense oligonucleotide-based progranulin augmentation therapy in neurodegenerative diseases

 #11
20200318109
2020-10-08

LNA-G process

 #12
20200291407
2020-09-17

TREATMENT OF GLIAL CELL DERIVED NEUROTROPHIC FACTOR (GDNF) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO GDNF

 #13
20200283801
2020-09-10

Exosomal loading using hydrophobically modified oligonucleotides

 #14
20200157537
2020-05-21

Modulating RNA Interactions with Polycomb Repressive Complex 1 (PRC1)

 #15
20190383797
2019-12-19

Methods of selecting therapeutic molecules

 #16
20190194655
2019-06-27

POLYNUCLEOTIDE CONSTRUCTS HAVING AN AUXILIARY MOIETY NON-BIOREVERSIBLY LINKED TO AN INTERNUCLEOSIDE PHOSPHATE OR PHOSPHOROTHIOATE

 #17
20190055550
2019-02-21

LNA-G Process

 #18
20190040394
2019-02-07

TREATMENT OF GLIAL CELL DERIVED NEUROTROPHIC FACTOR (GDNF) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO GDNF

 #19
20190032091
2019-01-31

Nuclease-mediated genome editing of primary cells and enrichment thereof

 #20
20180312536
2018-11-01

Immunomodulating polynucleotides, antibody conjugates thereof, and methods of their use

 #21
20170275618
2017-09-28

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF MYC BY DOUBLE-STRANDED RNA

 #22
20170226516
2017-08-10

TREATMENT OF GLIAL CELL DERIVED NEUROTROPHIC FACTOR (GDNF) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO GDNF

 #23
20170183686
2017-06-29

Exosomal loading using hydrophobically modified oligonucleotides

 #24
20160281091
2016-09-29

METHODS AND COMPOSITIONS FOR THE SPECIFIC INHIBITION OF MYC BY DOUBLE-STRANDED RNA

 #25
20160257961
2016-09-08

POLYNUCLEOTIDE CONSTRUCTS HAVING DISULFIDE GROUPS

 #26
20160076031
2016-03-17

Phosphorous-linked oligomeric compounds and their use in gene modulation

 #27
20150275283
2015-10-01

Modified cytosine polynucleotide oligomers and methods

 #28
20150094358
2015-04-02

Treatment of hepatocyte growth factor (HGF) related diseases by inhibition of natural antisense transcript to HGF

 #29
20140343264
2014-11-20

Neutral nucleic acid ligands

 #30
20130184325
2013-07-18

TREATMENT OF HEPATOCYTE GROWTH FACTOR (HGF) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO HGF

 #31
20120329855
2012-12-27

Treatment of hepatocyte growth factor (HGF) related diseases by inhibition of natural antisense transcript to HGF

 #32
20120142763
2012-06-07

NUCLEIC ACID DELIVERY COMPOSITIONS AND METHODS OF USE THEREOF

 #33
20110319476
2011-12-29

TREATMENT OF GLIAL CELL DERIVED NEUROTROPHIC FACTOR (GDNF) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO GDNF

 #34
20100292301
2010-11-18

NOVEL SIRNA STRUCTURES

 #35
20100261779
2010-10-14

Phosphate-modified oligonucleotide analogs with enhanced immunostimulatory activity

 #36
20100151458
2010-06-17

OLIGORIBONUCLEOTIDES AND RIBONUCLEASES FOR CLEAVING RNA

 #37
20090270486
2009-10-29

HUMAN RNASE III AND COMPOSITIONS AND USES THEREOF

 #38
20090192113
2009-07-30

Interfering RNA duplex having blunt-ends and 3′-modifications

 #39
20070299022
2007-12-27

Antisense oligonucleotide to inhibit melanoma inhibitory activity, MIA

 #40
20070238686
2007-10-11

Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to Grb2 or Crk1

 #41
20070203084
2007-08-30

Interfering Rna Duplex Having Blunt-Ends And 3'-Modifications

 #42
20050202541
2005-09-15

Three component chimeric antisense oligonucleotides

 #43
20050159384
2005-07-21

Human RNase III and compositions and uses thereof